Evidence map›Paper›PMID 41513234›Full record

ArticleAnalytical chemistry2026

Antimicrobial Peptide Activity in Lipid Bilayers with Smooth-Type Lipopolysaccharides.

Wakana Hashimoto, Nanami Takeuchi, Yuki Hagiri, Mana Sato, Ryuji Kawano

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wakana HashimotoDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.
Nanami TakeuchiDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.
Yuki HagiriDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.
Mana SatoDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.
Ryuji KawanoDepartment of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.ORCID 0000-0001-6523-0649

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance has emerged as a global health concern, highlighting the need for alternative therapeutic strategies to conventional antibiotics. Antimicrobial peptides (AMPs) are promising candidates because they kill bacteria mainly by disrupting the membranes and have a lower propensity to induce resistance. Therefore, it is essential to clarify their molecular interactions with bacterial membranes. Although several methods have been proposed to form planar lipopolysaccharide (LPS) bilayers, producing and maintaining stable free-standing LPS-containing membranes remains challenging, particularly for smooth-type LPS bearing the O-antigen. In this study, we establish a microdevice-based droplet contact method that reconstitutes an outer-membrane (OM) model that includes smooth-type LPS. Electrophysiological evaluation of four AMPs (Mag2, Ovi, PG-1, Bac) using this method showed that AMPs interact with the OM mainly through penetration and act on the inner membrane (IM) by inducing both penetration and pore formation. Furthermore, when we scored the electrophysiological parameters for the OM and IM and integrated these scores, the correlation with minimum inhibitory concentration (MIC) reached

Indexed as

Antimicrobial PeptidesLipid BilayersLipopolysaccharidesMicrobial Sensitivity TestsAntimicrobial PeptidesLipid BilayersLipopolysaccharides

Identifiers

PMID41513234
PMCPMC12892248

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.